
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with …
2019年11月8日 · KALM-1 was a randomized, double-blind, placebo-controlled, phase 3 trial that was conducted at 56 sites in the United States; an open-label extension phase to evaluate …
NeurIPS 2024 | KALM:大语言模型的知识可用于强化学习训练
2024年10月29日 · 分享一下我们NeurIPS 2024 大语言模型 驱动强化学习的工作KALM:《Knowledgeable Agents by Offline Reinforcement Learning from Large Language Model …
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus
2020年1月16日 · The imputed percentage of patients with a decrease of at least 3 points in the WI-NRS score was 49.1% in the difelikefalin group, as compared with 27.9% in the placebo …
Difelikefalin for the treatment of moderate-to-severe pruritus ...
2023年4月13日 · 4.3.1. KALM-1 and KALM-2 studies [Citation 30] KALM-1 was a double-blind, placebo-controlled, phase 3 trial. Hemodialysis patients with moderate-to-severe pruritus were …
Efficacy of Difelikefalin for the Treatment of Moderate to Severe ...
2022年6月28日 · KALM-1 and KALM-2 were conducted in accordance with ethical principles founded in the Declaration of Helsinki, International Council for Harmonization principles of …
KALM
KALM enables LLM to imagine novel rollouts unseen before. In (a), LLM is never trained with data containing "wall", but it raises the robotics arm to avoid colliding the wall. In (b), LLM is only …
慢性肾病相关性瘙痒新药Kapruvia(difelikefalin)注射液获欧盟推 …
2022年3月2日 · 欧盟CHMP的积极意见、以及美国 FDA 的批准,均基于2项关键3期临床试验(KALM-1,KALM-2)的阳性数据,以及来自额外32项临床研究的支持性数据。 在3期 临床试 …
FDA批准治疗CKD相关瘙痒药物difelikefalin - 健康界
2021年8月25日 · 在KALM-1试验中,伴有中度至重度CKD-aP的血液透析患者,接受Korsuva注射液治疗后,瘙痒强度和生活质量指标均表现出统计学意义的显著改善。 …
First Kalma in Arabic and English Translation (1st Kalma)
The First Kalma is known as the Kalma Tayyibah (The Pure Word). It is a declaration of faith that emphasizes the oneness of Allah and the prophethood of
KaLM系列文本Embedding开源 - 知乎 - 知乎专栏
我们很高兴地宣布推出KaLM系列最新的Embedding模型: KaLM-embedding-multilingual-mini-instruct-v1.5 ,基于0.5B规模自回归模型,在 MTEB基准 上取得了领先的表现,欢迎大家试用 …